AbCellera Biologics(ABCL)
Search documents
AbCellera Biologics(ABCL) - 2021 Q4 - Annual Report
2022-02-24 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39781 AbCellera Biologics Inc. (Exact name of Registrant as specified in its Charter) British Columbia Not Applicable (State or other ...
AbCellera Biologics(ABCL) - 2021 Q3 - Earnings Call Transcript
2021-11-10 02:09
Abcellera Biologics, Inc. (NASDAQ:ABCL) Q3 2021 Earnings Conference Call November 9, 2021 5:00 PM ET Company Participants Tryn Stimart - Chief Legal Officer, Chief Compliance Officer & Corporate Secretary Carl Hansen - President, CEO & Director Andrew Booth - CFO Conference Call Participants Gal Munda - Berenberg Capital Stephen Willey - Stifel, Nicolaus & Company Puneet Souda - SVB Leerink Operator Good day, and thank you for standing by. Welcome to the AbCellera Q3 2021 Earnings Results and Business Updat ...
AbCellera Biologics(ABCL) - 2021 Q2 - Earnings Call Transcript
2021-08-13 01:56
AbCellera Biologics Inc. (NASDAQ:ABCL) Q2 2021 Earnings Conference Call August 12, 2021 5:00 PM ET Company Participants Tryn Stimart - Chief Legal Officer & Chief Compliance Officer Carl Hansen - CEO & President Andrew Booth - CFO Conference Call Participants Tiago Fauth - Credit Suisse Gal Munda - Berenberg Stephen Willey - Stifel Gary Nachman - BMO Capital Operator Good afternoon, and welcome to AbCellera’s Second Quarter 2021 Financial Results Conference Call. My name is Mel, and I will facilitate the au ...
AbCellera Biologics(ABCL) - 2021 Q1 - Earnings Call Transcript
2021-05-14 01:51
AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2021 Earnings Conference Call May 13, 2021 5:00 PM ET Company Participants Tryn Stimart - Chief Legal Officer & Chief Compliance Officer Carl Hansen - Chief Executive Officer & President Andrew Booth - Chief Financial Officer Conference Call Participants Tiago Fauth - Credit Suisse Stephen Willey - Stifel Gal Munda - Berenberg Puneet Souda - SVB Leerink Do Kim - BMO Operator Good day and thank you for standing by. Welcome to the AbCellera Q1 2021 Earnings Results an ...
AbCellera Biologics(ABCL) - 2020 Q4 - Earnings Call Transcript
2021-03-30 02:50
AbCellera Biologics, Inc. (NASDAQ:ABCL) Q4 2020 Earnings Conference Call March 29, 2021 5:00 PM ET Company Participants Tryn Stimart – Chief Legal Officer, Chief Compliance Officer and Corporate Secretary Carl Hansen – President and Chief Executive Officer Andrew Booth – Chief Financial Officer Conference Call Participants Tiago Fauth – Credit Suisse Stephen Willey – Stifel Gal Munda – Berenberg Puneet Souda – SVB Leerink Do Kim – BMO Operator Good day and thank you for standing by. Welcome to the AbCellera ...